Ledger.Open graph →
SEC Form D · Amendment · filed August 8, 2024

Flow Pharma, Inc

Offering
$40.0M
Sold
$225K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WARRENSVILLE HEIGHTS, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Tikoes M. Blankenberg · Warrensville Heights, OHDirectorPamela M. Steele · Warrensville Heights, OHDirectorBabatunde M. Otulana · Warrensville Heights, OHDirectorAnthony M. Tufaro · Warrensville Heights, OHDirectorReid M. Rubsamen · Warrensville Heights, OHExec · DirectorConor B. Tierney · Pleasanton, CADirectorTimothy J. Dunn · Pleasanton, CADirectorMatthew Fisch · Pleasanton, CAExec · DirectorMarques Colston · Fargo, NDDirectorAnthony M. Tufaro · Warrensville Heights, OHDirectorChris Kenny · Austin, TXExec · DirectorDustin Pridmore · Dallas, TXDirectorMichael Terry · Dallas, TXDirectorRobert F. Nanney · Chicago, ILDirectorPaul England · Bee Cave, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗